Podcasts about nvo

This week on Dividend Talk, Derek is joined by Jeremy from Dividend Stockpile to explore some of the biggest Megatrends shaping our investing future. We cover the opportunities and risks in infrastructure, clean energy, technology, and healthcare, and how dividend investors can position themselves for the next decade and beyond.You'll hear about recent dividend news from Interface (TILE) and Agree Realty (ADC), how US and European infrastructure approaches differ, why utilities like Iberdrola (IBE.MC) and Enel (ENEL.MI) stand out, and how tech giants Meta (META), Alphabet (GOOG), and Microsoft (MSFT) fit into the AI megatrend. We also look into healthcare innovation, options income strategies, and favourite finance content creators.Tickers Mentioned: TILE, ADC, O, BAM, BIP, NEE, DUK, ED, IBE.MC, ENEL.MI, ABB, DG.PA, META, GOOG, MSFT, GE, CWEN, ASML.AS, SAP, MDT, MRK, ABBV, NVO, LLY, ROG.SW, SNY, SYK, ABT, BDX, RMD, STRCChapters:00:00 – Introduction & Guest Welcome02:52 – Company News: Interface & Dividend Increases05:41 – Agree Realty & REIT Quality08:43 – Understanding Megatrends11:51 – Infrastructure as a Megatrend29:06 – Clean Energy Transition39:31 – The Rise of Technology & AI46:51 – Healthcare Opportunities01:04:06 – Options Income Strategies & High Yield Ideas01:20:06 – Favorite Finance Content Creators & Closing RemarksGet a free sample of our premium dividend newsletter! Stay ahead of the market with in-depth stock analysis here: https://dividendtalk.eu/download-your-free-samples/ Stay Updated:Twitter - @DividendTalk_Twitter - @European_DGIJoin our Facebook Community - Dividend Talk Facebook GroupJoin our Discord group - https://discord.gg/nJyt9KWAB5

In this week's episode of Dividend Talk, we kick off with our Q2 performance review , looking at how our dividend portfolios fared, what we bought, sold, and learned over the past quarter.  We also dive into three big names making headlines: Wolters Kluwer's sharp share price drop and the fear of AI disruption, Novo Nordisk's earnings and competition with Eli Lilly, and UnitedHealth's reduced outlook.  Along the way, we cover dividend hikes and cuts from around the globe, have some laughs over corporate slogans, and answer a packed list of listener questions ranging from sector risks to portfolio construction. SEE YOU ON THE INSIDE!! Tickers discussed: WKL.AS, NVO, LLY, UNH, HEIA.AS, NN.AS, AD.AS, ITW, CLX, AWR, WHR, LGEN.L, MRK, LVMH.PA, TGT, LYB, NKE,CVX, HPQ, MSFT, SHEL, BTI, BAM, BAES.L, HORNB.BR, UPS, PEP, CCOI, ORA.PA,ASR.AS, ASML.AS, UL, GLB.IR, KRZ.F, KESKOB.HE, KNEBV.HE, SAMPO.HE, AGE.BR, XIOR.BR,ASC.BR, SHL.DE, DEF.F, NVO-B.CO, VICI, RY, DOL.TO, FTS.TO, UKW.L, VOLVB.ST,INVE-A.ST, INVE-B.ST, SEB-A.ST, SWED-A.ST, HAND-B.ST, SHELL.AS, VIE.PA, O,SECUB.ST, ABBV, BAYN.DE.  Join us :[Facebook]  - Https://www.facebook.com/groups/dividendtalk[Twitter] -   @DividendTalk_    ,  @European_DG[Discord] - https://discord.gg/nJyt9KWAB5[Premium Services] - https://dividendtalk.eu/how-it-works

My portfolio was way up yesterday - it's happened during 2 kinds of periods in the market. And we've got another day of HUGE earnings. Plus some other opportunities. Here are the links to all the sales: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SAVE ON TRENDSPIDER - GET THE ANNUAL SUBSCRIPTION TO GET MY 4 HOUR ALGORITHM ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Summary del Show: • Wall Street arranca al alza con la Fed en el centro del escenario, mientras se esperan señales de Powell y los resultados de $MSFT y $META tras el cierre. • $SBUX sube tras sorprender con ventas y un plan agresivo de renovación, destacando su crecimiento en China y nuevas inversiones en tiendas y servicio. • $NVO cae al recortar su guía 2025 por menor demanda de semaglutida en EE.UU., aunque analistas ven la caída como oportunidad de compra. • Google $GOOGL acepta firmar el Código de IA de la UE, a pesar de las tensiones sobre derechos y competitividad.

Between battered industries and overlooked opportunities, plenty of dividend-paying companies have slipped to the bottom of the earnings jar. Today, Emily Flippen, Matt Argersinger, and Ant Schiavone dig into: The shrinking ranks of “Dividend Knight” contenders Healthcare stocks with hard times but high yields What investors should prioritize in dividend-paying stocks Companies discussed: NVO, UNH, WHR, PLD, CNQ, SCHDHost: Emily Flippen, Anthony Schiavone, Matthew ArgersingerProducer: Anand ChokkaveluEngineer: Adam Landfair, Natasha HallDisclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit ⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Stocks closed down as tariff talks between the U.S. and China continued for a second day in Sweden. Most earnings didn't offer hope for positive trading action, seen in Novo Nordisk's (NVO) 22% decline after curbing sales expectations for Wegovy and Ozempic. Spotify (SPOT) also saw a staggering sell-off after posting a surprise miss. However, SoFi Technologies (SOFI) offered a bright spot with its rally. Marley Kayden talks about the biggest earnings movers of the session.======== Schwab Network ========Empowering every investor and trader, every market day.Options involve risks and are not suitable for all investors. Before trading, read the Options Disclosure Document. http://bit.ly/2v9tH6DSubscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

Summary del Show: • Mercado mixto antes de datos clave: Los futuros abrieron casi sin cambios tras rumores sobre Powell y un IPP suave. Hoy destacan ventas minoristas, solicitudes de desempleo y resultados de $NFLX. • Avanza legislación cripto en el Congreso: La Cámara impulsa tres leyes clave, incluyendo el GENIUS Act y el CLARITY Act; se espera voto final esta semana. • Europa lanza supercomputadora cuántica con $MSFT: Dinamarca y la fundación de $NVO invertirán 93 Millones de dólares en el proyecto QuNorth para competir globalmente. • WeRide lanza primer Robobus sin operador en Asia sudoriental: El servicio opera en Singapur y marca un hito en movilidad autónoma, mientras la acción sube +1.48%.

Amazon's latest data center will require the same amount of electricity as one million homes. (00:21) Jason Moser and Matt Argersinger join Ricky Mulvey to discuss: - The data center spending boom. - Hims & Hers messy breakup with Novo Nordisk. - Overrated and underrated business stories from the year so far. (19:11) Progyny CEO, Peter Anevski, joins Tim Beyers and Holly Anderson to discuss the growth path ahead for the health benefits company. (31:28) Jason and Matt discuss Disney's box office struggle with “Elio” and offer up two radar stocks: Uber and Otis Worldwide. Companies discussed: AMZN, HIMS, NVO, TSLA, PGNY, DIS, UBER, OTIS Host: Ricky Mulvey Guests: Jason Moser, Matt Argersinger, Tim Beyers, Holly Anderson, Peter Anevski Engineer: Dan Boyd Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, "TMF") do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit megaphone.fm/adchoices

Novo Nordisk parts ways with Hims & Hers, a financials-related stock to get on your radar and more! Jason Moser and Matt Frankel discuss: - Why Novo Nordisk is parting ways with Hims & Hers. - Waymo and Uber's big Atlanta debut. - What the potential tax deduction on autos could mean for consumers and companies. - Matt has a financials-related stock he thinks is worth a closer look. Tickers mentioned: NVO, HIMS, TSLA, UBER, GOOG, GM, ALLY, RKT Host: Jason Moser Guest: Matt Frankel Engineer: Dan Boyd Learn more about your ad choices. Visit megaphone.fm/adchoices

En este episodio cubrimos los eventos más relevantes antes de la apertura del mercado: • Wall Street sube pese a tensiones en Medio Oriente: Futuros en verde: $SPX +0.8%, $US100 +1.2%, $INDU +0.8%. Los rendimientos del Treasury caen levemente. Israel acusó una violación del alto al fuego y amenaza con represalias, mientras Irán niega nuevos ataques. El permiso para civiles de abandonar refugios en Israel trajo algo de alivio. Hoy se publican datos de precios de vivienda, confianza del consumidor y testifica Powell en el Congreso. • IBM despliega sistema cuántico avanzado en Japón: $IBM y el laboratorio RIKEN inauguraron el primer IBM Quantum System Two fuera de EE.UU., ubicado en Kobe. El sistema utiliza el procesador Quantum Heron de 156 cúbits, el más avanzado de la compañía. Apoyado por NEDO, el proyecto busca combinar supercomputación y computación cuántica en la era post-5G. • Novo Nordisk lanza Wegovy en India: $NVO presentó oficialmente su medicamento para pérdida de peso en el mercado indio. Wegovy se venderá en cinco dosis, con un costo mensual entre $50 y $312. La competencia con $LLY se intensifica tras el lanzamiento de Mounjaro en el país. $NVO +1.95% premarket. • Mastercard y Fiserv integran stablecoin FIUSD: $MA fortalece su alianza con $FI al integrar la stablecoin FIUSD en su red global. La plataforma digital de Fiserv se lanzará en 2025 y busca facilitar soluciones para bancos y adquirentes. $FI +6% premarket tras el anuncio. Una jornada con atención en geopolítica, avances tecnológicos y nuevos frentes en salud y pagos digitales. ¡No te lo pierdas!

Hims & Hers (HIMS) shares are reeling after Novo Nordisk (NVO) severs its weight-loss drug relationship with the telehealth company. NVO claims HIMS was marketing knock-off weight loss drugs using "deceptive promotion" tactics. George Tsilis weighs in on why HIMS is down 30% on the news, and how it impacts the company's personalization care business segment. He points to possible red flags with ingredients coming from China and a lack of quality control over the use of weight-loss medication.======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

In this episode of The EA Campus Podcast, we sit down with freelance Executive Assistant Kaitlin Bekken for one of our ever-popular Day in the Life conversations.Caitlyn shares her journey into the EA world, how she transitioned into freelancing, and what a typical day looks like supporting multiple clients across industries. From managing inboxes and booking complex travel to using AI tools like ChatGPT and NVO to streamline her workflow, Caitlyn walks us through the systems and mindset that keep her on top of her game.We also dive into the importance of knowing your own working capacity, how to build strong remote relationships with executives, and the career-defining power of problem-solving and tenacity.Whether you're an in-house EA curious about life as a freelancer, or a virtual assistant looking to refine your own approach, Caitlyn's insights are full of practical wisdom, humour, and reassurance.In this episode:Caitlyn's journey into the EA role and her move into freelancingHow she manages her day across multiple clients and time zonesHer favourite tools and tech, including ChatGPT and NVOBuilding trust remotely and setting healthy boundariesAdvice for new EAs (and why “just go for it” might be your new motto) The EA Campus

Već mjesecima traje rasprava o ulaganjima arapske firme Eagle Hills na Velikoj plaži u Ulcinju. Vlada najavljuje razvojni bum, dok lokalna zajednica, opozicija i NVO sektor upozoravaju na netransparentnost i moguće zloupotrebe. Nakon protesta 15. maja i najave investitora Mohameda Alabara da bi se mogao povući, ostaje pitanje: je li ovo još jedan sumnjiv tender za crnogorsku obalu? Maja Marić razgovara s aktivistom Mustafom Cankom, a kolegica Vesna Rajković donosi priču o pozadini. Von Maja Maric.

Nova njemačka vlada počela je od prvog dana ispunjavati svoje obećanje iz predizborne kampanje i doslovno zatvorila granice za tzv. neregulirano useljavanje. Koliko ta nova politika strogoće ima uspjeha i kako na nju reagiraju kritičari i NVO? Nenad Kreizer razgovara s reporterom Filipom Slavkovićem i Petrom Rosandićem iz bečke nevladine organizacije SOS Balkanroute o izgledima nove migracijske politike. Von Nenad Kreizer.

In this episode of Dividend Talk, we dive into the drama at UnitedHealth Group (UNH) from earnings disappointments to fraud allegations and a sudden CEO exit. Is it a buying opportunity or a classic falling knife?We also break down strong earnings from two European giants: Siemens (SIE.DE) and Allianz (ALV.DE). Both companies delivered rock-solid results, reminding us why Europe is a fertile ground for dividend growth investors.Along the way, we reflect on what we'd do differently if we started our investing journeys today, why conviction matters more than share price, and whether preferred stocks or spin-offs like Magnum are worth a look.

In this episode, we dive into Warren Buffett's succession and legacy, the philosophy that built Berkshire Hathaway, and what the future might hold under Greg Abel. We also break down recent dividend news, from Apple's modest hike to Wendy's surprising cut, and share our own May dividend income.We cover earnings from some major names like Novo Nordisk, Archer Daniels Midland, Ahold Delhaize, and Legrand, plus explore the intriguing possibility of Shell acquiring BP. Listener questions spark some great discussion, including what football clubs would be as dividend stocks, whether our podcast can move markets, and which companies have the strongest moats.

Fed Chair Powell and team want to see more before making changes to interest rates, and automakers are an early sign price increases might be coming in response to tariffs. (00:21) Tim Beyers and Bill Mann discuss: - The Fed's continued wait and see approach to tariff policy, inflation, and interest rate cuts. - Ford's warning of tariff impacts, and why MercadoLibre is worth a look amid the macro uncertainty. - How Uber and DoorDash are both flourishing as they cash in on the delivery market and consumer laziness. (19:11) Fool contributor Jason Hall talks through his time at Berkshire Hathaway's annual meeting in Omaha, Warren Buffett's plans to step down as CEO, and what to expect next from Greg Abel. (31:12) Bill and Tim break down two stocks on their radar: Apple and Ibotta. Stocks discussed: F, MELI, DASH, UBER, NVO, BRK.A, BRK.B, AAPL, BAC, IBT Host: Dylan Lewis Guests: Bill Mann, Tim Beyers, Jason Hall Engineers: Dan Boyd Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, "TMF") do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. Learn more about your ad choices. Visit megaphone.fm/adchoices

En este episodio cubrimos lo más relevante antes de la apertura de Wall Street: • Wall Street se anima por reunión EE.UU.–China: Futuros al alza: $SPX, $US100 y $INDU +0.6%. La expectativa de avances comerciales se suma a la espera por la decisión de tasas de la Fed. Se anticipa que el FOMC mantenga tasas sin cambios, pero el foco está en las palabras de Jerome Powell tras la presión pública de Trump por recortes. • Cisco impulsa su apuesta cuántica: $CSCO presentó su chip Quantum Network Entanglement y abrirá un laboratorio en California. Tecnología de baja energía, operativa a temperatura ambiente y con hasta 200M pares de entrelazamiento por segundo. Se suma a la carrera cuántica junto a $GOOG, $MSFT, $AMZN y $NVDA. • CoreWeave fortalece su músculo financiero: $CRWV eleva su línea de crédito de $650M a $1.5B con bancos como JPMorgan y Goldman Sachs. Busca expandir infraestructura de nube enfocada en IA. Pese a tensiones pasadas por deuda, las entidades muestran confianza en su crecimiento futuro. • Novo Nordisk ajusta guía, pero sube: $NVO reportó ingresos por $11.9B (+19% YoY) en Q1 2025, aunque ventas de Wegovy decepcionaron. Aun así, la acción sube al anticipar recuperación en ventas tras el cierre de vacíos regulatorios en EE.UU. Nueva guía: +13%-21% en ventas para el año. Un episodio cargado de noticias clave antes de que arranque el mercado. ¡No te lo pierdas!

S&P Futures are displaying gains this morning as the market reacts to the latest trade related news. After the bell yesterday it was announced that the U.S. and China will meet this week to start trade negotiations. This afternoon there is a Fed announcement along with a Powell press conference. A change in rates is not expected as the Fed is inclined to wait for more data - Markets are currently expecting a rate cut to occur in the July meeting. On the earning front, AMD and ANET both reported beats last night, but the reports were not entirely positive. NVO & DIS are higher after their earnings announcements. After the bell today ARM, APP, FTNT & CVNA are set to report.

En este episodio cubrimos lo más relevante antes de la apertura de Wall Street: • Wall Street se anima por reunión EE.UU.–China: Futuros al alza: $SPX, $US100 y $INDU +0.6%. La expectativa de avances comerciales se suma a la espera por la decisión de tasas de la Fed. Se anticipa que el FOMC mantenga tasas sin cambios, pero el foco está en las palabras de Jerome Powell tras la presión pública de Trump por recortes. • Cisco impulsa su apuesta cuántica: $CSCO presentó su chip Quantum Network Entanglement y abrirá un laboratorio en California. Tecnología de baja energía, operativa a temperatura ambiente y con hasta 200M pares de entrelazamiento por segundo. Se suma a la carrera cuántica junto a $GOOG, $MSFT, $AMZN y $NVDA. • CoreWeave fortalece su músculo financiero: $CRWV eleva su línea de crédito de $650M a $1.5B con bancos como JPMorgan y Goldman Sachs. Busca expandir infraestructura de nube enfocada en IA. Pese a tensiones pasadas por deuda, las entidades muestran confianza en su crecimiento futuro. • Novo Nordisk ajusta guía, pero sube: $NVO reportó ingresos por $11.9B (+19% YoY) en Q1 2025, aunque ventas de Wegovy decepcionaron. Aun así, la acción sube al anticipar recuperación en ventas tras el cierre de vacíos regulatorios en EE.UU. Nueva guía: +13%–21% en ventas para el año. ¡Dale play y entérate de todo lo que mueve el mercado hoy!

S&P Futures are trading higher this morning with markets displaying positive action on an easing of trade tensions between the U.S. & China. China said that it was mulling a halt to the trade war, but only if the U.S. considered canceling unilateral tariffs. Markets continue to focus on earnings, AAPL and AMZN are displaying losses this morning are earnings releases Thursday night. Next week PLTR, F, DDOG, AMD, ANET, UBER, DIS, NVO, ARM, APP, DASH, SHOP, MCK, DKNG & COIN are set to release. On the economic front, this morning's Non-Farms Payrolls report will be widely watched. There is an FOMC meeting next week, the Fed is expected to make to changes to its interest rate policy.

Karen Anderson, director of healthcare equity research for Morningstar Research Services, discusses the forces shaping the landscape and where she sees opportunities for investors.  Key Takeaways:Why Healthcare Stocks Have Been Resilient During the Market DownturnHow Regulatory Changes Could Affect the Healthcare IndustryWhy Healthcare Stocks' Valuations Look Attractive From a Bottom-Up ViewHow Have Healthcare Stocks' Valuations Changed Historically?How Stock Valuations Differ Within the Healthcare Sector  How an Aging US Population Affects the Healthcare Sector  Will GLP-1 Drugs Continue to Grow?  Regulatory Risks for Healthcare Stocks  Healthcare Stocks Outlook  Are Healthcare Stocks a Buy?  Healthcare Stock Picks  How Amgen Is Using AI in Healthcare   Read about topics from this episode.  Healthcare: Sector Looks Undervalued with Pullback After US Election and Obesity DataNovo Nordisk: Next-Generation GLP-1/Amylin Drug Sees Leading Weight Loss in Small TrialHow GLP-1 Drugs Like Ozempic Are Boosting Biopharma StocksBiopharma Stock Election Impact: Potential Reduced IRA Headwind but Unpredictable Challenges22 Best Healthcare Companies to Invest In  What to watch from Morningstar.Worried About a Market Sell-Off? These 10 Funds Reduce Portfolio Risk Gray Divorce: How to Avoid Triggering a Costly Tax BillWhy the Bond Market Looks Brighter Than It Did in 2022Where to Find Bargain Stocks in an Expensive Market  Read what our team is writing:Karen AndersenSarah Hansen Follow us on social media.Facebook: https://www.facebook.com/MorningstarInc/X: https://x.com/MorningstarIncInstagram: https://www.instagram.com/morningstar... LinkedIn: https://www.linkedin.com/company/5161/ 

Nevyriausybinės organizacijos ir bendruomenės atlieka gyvybiškai svarbų vaidmenį, kuriant teisingesnę ir tvaresnę visuomenę. Jau ne kartą įsitikinome, kad organizuota ir gerai valdoma bendruomenė tikrai gali daug. Ir psichologai sako, kad bendravimas bei bendradarbiavimas su bendraminčiais labai svarbus kiekvienam žmogui.„Atviros Lietuvos fondo organizuojama programa VERTA skirta žmogaus teisių srityje veikiančių nevyriausybinių organizacijų gebėjimų stiprinimui ir jų vykdomiems projektams finansuoti. Programos dėmesio centre – organizacijos ir projektai, siekiantys įtraukti pažeidžiamas grupes ir asmenis, užtikrinti jų lygiateisiškumą, skatinti solidarumą, bei gerinti pilietinio ir demokratinio dalyvavimo sąlygas. Ypač daug dėmesio skiriama vietos lygmeniu veikiančioms, mažoms NVO stiprinti“, - taip pristato programą organizatoriai.Kaip ši programa gyvena realų gyvenimą, ko mokoma „NVO lyderių akademijoje“, kodėl dirbantiesiems nevyriausybinėse organizacijose svarbu mokytis ir kokius pokyčius inicijuoja „NVO lyderių akademijos“ absolventai, laidoje kalbamės su Atviros Lietuvos fondo programų vadove Marta Gadeikiene ir VšĮ „Tapk laisvas“ socialine darbuotoja, projektų koordinatore ir NVO lyderių akademijos absolvente Rūta Gerasime.Ved. Žydrė Gedrimaitė

Tracey Ryniec and Zacks Chief Equity Strategist, John Blank, discuss the state of the economy and what stocks to invest in after the stock sell-off.  (1:00) - Are We Heading Towards A Recession? (7:10) - What Can We Expect From The Fed The Next Few Months? (12:30) - How Should You Position Your Portfolio Right Now? (17:40) - Top Stocks To Keep On Your Watchlist (28:30) - Episode Roundup: ABBV, XOM, FANG, JPM, NVDA, TSLA, NVO, LLY, GPC

Mike Nedelcovych surveys the GLP-1 space after the FDA declared the shortage over, boosting makers like NVO and LLY and hurting compounding pharmacies like HIMS, who will stop offering the drugs. He thinks GLP-1s have the “wind at their back,” but notes that the government may be cracking down on Medicare/Medicaid use of the drugs. However, he says that Medicare expansion would be “icing on the cake.”======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

Da li su upad u NVO sektor i hapšenja u sklopu borbe protiv korupcije dokaz da institucije rade ili da ne rade?Gost Danice Vučenić u Iza vesti je sudija Apelacionog suda i inicijator Proglasa Miodrag Majić.

En este episodio, desglosamos los eventos clave que están marcando la agenda de los mercados y la innovación tecnológica: Wall Street en rebote tras semana negativa: El $SPX sube +0.6% luego de su peor sesión del año. Analizamos los factores detrás de la caída del viernes y qué esperar con los reportes de $HD, $LOW y $NVDA esta semana. Alibaba invierte fuerte en IA: $BABA anuncia un plan de $52.44B en computación en la nube, superando su gasto total en la última década. Evaluamos cómo su modelo Qwen2.5-VL busca competir con GPT-4o, Claude 3.5 Sonnet y Gemini 2.0. Apple responde a los aranceles con una inversión récord: $AAPL destinará más de $500B a EE.UU. en los próximos cuatro años, con énfasis en chips, software e IA. Exploramos su nueva fábrica en Houston y el impacto de la política comercial de Trump en su estrategia. Tesla lanza su primer servicio de robotaxis: $TSLA desplegará su tecnología Full Self-Driving en Austin, Texas, sin supervisión humana. Analizamos cómo este piloto será clave para la expansión nacional en 2026 con el Cyber Cab. Mercado de fármacos para obesidad en auge: TD Cowen eleva su estimación a $139B en 2030, con $LLY y $NVO liderando. Desglosamos cómo estos tratamientos están transformando la industria farmacéutica y qué otras empresas compiten en este sector. Acompáñanos para entender cómo estos eventos están impactando los mercados, la tecnología y la economía global. ¡Un episodio lleno de análisis estratégico!

This week, we dive into the latest European earnings season, exciting dividend hikes, and what they mean for investors! From Siemens, British American Tobacco, Ahold Delhaize, Agree Realty, and Unilever. We break down The biggest dividend hikes and what they signal.Tickers mentioned: META, NSRGY, BTI, BATS, AD.AS, ADC, UL, CSCO, TMUS, RELX, ORKLY, DNB, ENX, HEIA, MAND, STO, DBS, ROCK-B, QSR, BAM, TROW, NVO, SHEL, MSFT

The big game didn't live up to the big billing, but there was plenty to take in during commercial breaks and halftime. (00:14) David Meier and Dylan Lewis discuss: - HIMS taking a big swing at the weight-loss industry, trying to seize a tight window for acquiring customers that want GLP-1 drugs and shift public opinion on them. - Dunkin' and Starbucks taking very different approaches for morning coffee drinkers. - McDonald's lackluster Super Bowl ad and earnings results. WSJ article on HIMS: https://www.wsj.com/health/pharma/hims-super-bowl-ad-spotlights-weight-loss-drug-copycats-as-clock-ticks-on-their-business-3a225c5c (21:35) Robert Brokamp and Alison Southwick continue their conversation on 401ks and how you can get yours in better shape. Companies discussed: HIMS, LLY, NVO, SBUX, SKX, MCD Host: Dylan Lewis Guests: David Meier, Robert Brokamp, Alison Southwick Producer: Ricky Mulvey Engineers: Rick Engdahl Learn more about your ad choices. Visit megaphone.fm/adchoices

This week, we welcome Eli fromDividendology to the show! We will dive deep into dividend growth investing, discuss the latest dividend hikes, and gain insights into Eli's portfolio and strategy.

In this episode, we explore where value might be hiding in today's high-valuation market. From overlooked oil and gas plays to global opportunities in Japanese railways and Chinese big tech, we break down areas of potential interest for savvy investors. We also discuss the pitfalls and potential in pharma, defense, and precious metal miners, as well as the challenges pandemic darlings face in a post-COVID world. Plus, Braden dives into the concept of quality in investing, inspired by Dev Kantesaria of Valley Forge Capital. Discover why the intersection of growth and predictability defines great companies and how this framework can help you identify enduring opportunities in any market environment. Tickers of Stocks/ETFs discussed: HAL, TVK.TO, CNQ.TO, TOU.TO, ENB.TO, TRP.TO, KMI, MPC, JNJ, PFE, MRK, LLY, NVO, KVUE,PPH, IHE, ZHU.TO, LMT, UNP, 9020, KWEB, BABA, FNV.TO, WPM.TO, ABX.TO, NGT.TO, GDX, GDXJ, ZGD.TO, DOO.TO, 7309 Check out our portfolio by going to Jointci.com Our Website Canadian Investor Podcast Network Twitter: @cdn_investing Simon’s twitter: @Fiat_Iceberg Braden’s twitter: @BradoCapital Dan’s Twitter: @stocktrades_ca Want to learn more about Real Estate Investing? Check out the Canadian Real Estate Investor Podcast! Apple Podcast - The Canadian Real Estate Investor Spotify - The Canadian Real Estate Investor Web player - The Canadian Real Estate Investor Asset Allocation ETFs | BMO Global Asset Management Sign up for Finchat.io for free to get easy access to global stock coverage and powerful AI investing tools. Register for EQ Bank, the seamless digital banking experience with better rates and no nonsense.See omnystudio.com/listener for privacy information.

Outlook for options trading The landscape for trading worldwide amongst political and economic uncertainty globally The growth of prediction markets and demand for election contracts New budgeting tool Update on demand for overnight trading hours on IBKR's platform from this week's guest, Steve Sanders    NEW! DOWNLOAD THIS EPISODE'S AI GENERATED SHOW NOTES (Guest Segment) Steve Sanders is Executive Vice President of Marketing & Product Development at Interactive Brokers. In this capacity, he oversees all marketing and product development efforts at the company and introduces Interactive Brokers' low commissions, advanced trading technology and breadth of product worldwide to advanced individual and institutional investors globally. Steve joined Interactive Brokers in 2001 to establish the company's platform for financial advisors. Since that time, he has been responsible for many key initiatives including building a direct / digital marketing program, developing a new account structure and registration process for institutional investor clients and contributing to the deployment of the company's Integrated Investment Account.  During his over twenty-year tenure with the company, Steve has remained focused on providing IBKR clients with the products, tools and resources necessary to meet a wide variety of trading and investing objectives, which he believes has contributed to the company's extraordinary growth over the years. Prior to joining Interactive Brokers, Steve spent fifteen years at Citibank in a variety of positions including Managing Director and Chief Technology Officer of Cybic, a “Request for Quote” exchange to facilitate the distribution of OTC derivative products to retail investors, which he developed. Before that, he held diverse roles throughout the organization in credit & risk management, marketing, financial planning, and product structuring functions. Steve holds an MBA in Finance from the University of Chicago and an undergraduate degree from SUNY at Albany in Accounting and Computer Science. Check this out and find out more at: http://www.interactivebrokers.com/ Follow @andrewhorowitz Looking for style diversification? More information on the TDI Managed Growth Strategy - HERE Stocks mentioned in this episode: (NFLX), TSLA), (IBKR), (NVO), (KR)

En este episodio, desglosamos las pérdidas en los futuros del Nasdaq tras decepcionantes resultados de empresas como $WDAY y $DELL. Exploramos la recuperación de $MSTR con $BTC nuevamente al alza, y los desafíos de $AAPL en China tras una caída significativa en ventas de smartphones extranjeros. Además, $NVO logra una aprobación clave en Canadá para Wegovy, marcando un hito en el tratamiento de enfermedades cardiovasculares y manejo de peso. También analizamos cómo las tasas hipotecarias más bajas impulsaron la demanda de hipotecas y lo que los datos económicos de hoy podrían significar para las próximas decisiones de la Fed. ¡Mantente informado con los movimientos más importantes del mercado!

Pirmoje Planas dienai X laidų ciklo dalyje žiūrovai išgirs, kokiais būdais galima prisidėti prie visuotinės gynybos. Laidos dalyviai, atstovaudami skirtingas organizacijas, pasidalins savo pasiūlymais, kokius gebėjimus tiek žinių, tiek fizinius gali stiprinti žmonės, norintys prisidėti prie visuotinės neginkluotos gynybos. Taip pat, kokių veiksmų reikėtų imtis kiekvienam, atėjus dienai X. Laidoje diskutuoja: Karolina Savickytė - Mobilizacijos ir pilietinio pasipriešinimo departamento Pilietinio pasipriešinimo skyriaus patarėja; Žygimantas Solovjovas - Vilniaus miesto savivaldybės civilinės saugos skyriaus vedėjas, Paulius Tamolė - Krašto apsaugos savanorių pajėgų savanoris Luka Lesauskaitė - „Raudonasis kryžius“ komunikacijos vadovė Laidos vedėjas – Paulius Mikolaitis. 0:00 DIENA X 1:43 Kas yra visuotinė gynyba? 5:15 Būdai prisidėti 12:40 Kur kreiptis 19:23 Jaunimo pilietiškumas 22:58 Savivaldybės vaidmuo 25:08 Kiekvieno piliečio vaidmuo 30:22 Kaip stiprinti save 37:22 Kur rasti informaciją 44:34 NVO vaidmuo 48:58 Teorinė situacija

In this video, we'll perform a NVO stock analysis and figure out what Novo Nordisk looks like based on the numbers. Is Novo Nordisk stock a buy now?

Shares of Eli Lilly are up 150% over the last 2 years as investors are bullish about the new weight loss drugs. Is it too hot to handle? (1:00) - Breaking Down Eli Lilly's Performance: Is It Still Worth Buy Right Now? (11:30) - Taking A Look At The Competition: Is Their Valuation More Attractive? (17:20) - Episode Roundup: LLY, NVO

We discuss the market outlook and investing ideas for 2H 2024 (0:45) - Breaking Down The Market Rally: What Should We Expect From the Fed And Earnings? (7:45) - What Stocks And Industries Should Investors Keep On Their Radar Right Now? (12:00) - How Much Will Copper and Uranium Benefit From The AI Rally? (18:05) - Should You Be Buying ETFs that Implement Option Strategies? (24:00) - Episode Roundup: NVDA, MSFT, AMD, QQQM, QTUM, LLY, NVO, URNM, COPX, QQQY Podcast@Zacks.com

Jim Cramer killed $NVDA Bitcoin - buy now? $PFE in to GLP 1 - be careful $LLY and $NVO are the buys $C is a buy here $ONON - Motley Fool finally says buy $RCL - $TJX $WMT - BUYS $EXPE - may be a good one to get to gap fill on a pullback $MU earnings $XLU and $XLC - how to play these buys in the algorithm ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SEEKING ALPHA PREMIUM⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  - save up to 20% plus a FREE 7 day trial ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sign up for ALPHA PICKS here - SAVE $50. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ SIGN UP FOR TRENDSPIDER AND GET ALL OF THESE 1) My 4 hour algorithm 2) 65 Min algorithm to day trade with 3) Custom watch lists  4) Custom Scanners to find entries  TRENDSPIDER SALE - best offer available (limited time)  Sign up at the top link ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://linktr.ee/dailystockpick ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ (use code DSP25 if prompted) Email me at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠dailystockpick3@gmail.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  I'll send you all the algorithms, watchlists and scanners that you see me use each and every day.  Social Links and more - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://linktr.ee/dailystockpick⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  FREE NEWSLETTER WITH CHARTS - subscribe at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠dailystockpick.substack.com ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠SPONSORED BY VISIBLE - Check out this page - $20 off your first month - only $5 for the first month ⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Sign up for Webull and get free stocks like I did ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Get AT&T Fiber at your home - I have 1GB service ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.att.com/referral/code/?ref=TVY-3964⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  --- Send in a voice message: https://podcasters.spotify.com/pod/show/dailystockpick/message

ResMed has had the market on sleep apnea cornered for a while, but new weight-loss drugs might be creeping in. We look at what could change based on recent studies and some other businesses that have established lifelong customers. (00:21) Bill Barker and Dylan Lewis discuss: - How weight-loss drugs like Eli Lilly's Zepbound might be coming for ResMed and the sleep apnea market. - RXO take a bigger piece of the brokered transportation market, scooping up Coyote Logistics from UPS. - Target and Shopify linking up for a win-win partnership. (13:02) Tim Beyers and Ricky Mulvey discuss the value of lifetime-customer relationships, why they're huge for the likes of Apple, and Costco, and one lesser-known name that may have one too. Companies discussed: LLY, NVO, RMD, SPOT, AAPL, SNOW Host: Dylan Lewis Guests: Tim Beyers, Tim Beyers, Ricky Mulvey Producer: Ricky Mulvey Engineers: Dan Boyd Learn more about your ad choices. Visit megaphone.fm/adchoices

Nearly half of Americans say they're willing to pay for weight-loss drugs. But what are the downsides to these so-called “miracle drugs”? Johann Hari is the author of the book, “Magic Pill: The Extraordinary Benefits and Disturbing  Risks of the New Weight Loss Drugs.” Ricky Mulvey caught up with Hari for a conversation about: The medical magic that makes GLPs so effective Whether online pharmacies can responsibly prescribe these drugs Why there's a much larger market for these in the US than in other parts of the world To see where you can get a copy of “Magic Pill,” head to: www.magicpillbook.com Host: Ricky Mulvey Guest: Johann Hari Producer: Mary Long Engineer: Tim Sparks Companies discussed: NVO, LLY, ZM Learn more about your ad choices. Visit megaphone.fm/adchoices

Novo Nordisk and Eli Lilly have soared on GLP-1 weight-loss drugs – now Hims & Hers is trying to get in on the action with a more available and affordable option. (00:21) Asit Sharma and Dylan Lewis discuss: - Hims & Hers getting into the business of GLP-1 weight loss injections and what the compound market means for Novo Nordisk and Eli Lilly. - A sneaky company that's another winner in the weight-loss market. - Wix's successful pivot to a free-cash-flow orientation, and how the AI wave is pushing the company forward. (14:52) Gym stocks haven't worked out for most investors, Ricky Mulvey caught up with Motley Fool analyst Sanmeet Deo to find out why he has cooled on one fast-growing gym franchisor and a space in fitness that is investable. Companies discussed: HIMS, NVO, MCK, LLY, Wix Host: Dylan Lewis Guests: Asit Sharma, Ricky Mulvey, Mary Long Producer: Ricky Mulvey Engineers: Dan Boyd Learn more about your ad choices. Visit megaphone.fm/adchoices

This week: Rudy Maxa, Travel Journalist; Positive comments on Ben's NVO; Airlines: Biggest? Most Profitable? Biggest airline crown; Southwest expects fewer new planes; Concerns around lack of Boeing paperwork/security video; Empty middle seats on Frontier; Listener feedback on Doug Parker interview.

This week: Doug Parker, Fmr CEO, American Airlines, outlines serious TSA safety concerns. Ben's AI "New Voice Option" (NVO); Spirit & JetBlue go it alone - Next moves? New proposed rule for handling wheelchairs; Fare fact errors made by Tim Wu on CNBC; Listener Qs on useful life of a commercial aircraft, business model for airport lounges.

Tom and Ben discuss the read for today's Fed meeting, the Saudi Aramco announcement hurting oil servicers, Walmart stock split, and earnings from tech giants MSFT, GOOG, SWKS, and AMD as well as earnings from other companies including SBUX, CP, CB, MDLZ, NVO, TMO, and BA. For information on how to join the Zoom calls live each morning at 8:30 EST, visit https://www.narwhalcapital.com/blog/daily-market-briefingsPlease see disclosures:https://www.narwhalcapital.com/disclosure

Weight loss drugs are taking center spotlight, but other developing treatments could change how we live. Deidre Woollard caught up with Motley Fool biotech analyst Karl Thiel to discuss: - Biogen's next shot at an Alzheimer's treatment. - Why companies can't “muscle their way” into making new molecules. - How NVIDIA could change drug development.  - Moderna's vaccine strategy Companies discussed: LLY, NVO, GPCR, NVDA, DXCM, NVDA, BIIB, GEHC, MRNA, NVCR, VRTX Host: Deidre Woollard Guest: Karl Thiel Producer: Ricky Mulvey Engineer: Tim Sparks Learn more about your ad choices. Visit megaphone.fm/adchoices

Markets on fire - is it for real? Announcing a new Closest to the Pin! Household debt update - market thoughts and more... PLUS we are now on Spotify and Amazon Music/Podcasts! Click HERE for Show Notes and Links DHUnplugged is now streaming live - with listener chat. Click on link on the right sidebar. Love the Show? Then how about a Donation? Follow John C. Dvorak on Twitter Follow Andrew Horowitz on Twitter Warm Up - Following up on last week's data deluge - Wondering - was it a DCB or a BMR (Dead Cat Bounce - Bull Market Rally) - WeWork is now WeBroke - 70 hour workweek? - GUILTY -Another Shutdown countdown Market Update - Household Debt reaches milestone - South Korea "leveling the playing field" - Best week of 2023 - Apple Earnings (Does anyone care?) - Microsoft - Big Move Headline - U.S. stocks rose on Tuesday, with the S&P 500 and Nasdaq on track for their longest streak of gains in two years, as a retreat in U.S. Treasury yields buoyed megacap growth stocks and investors sought more clarity on interest rates from the Federal Reserve. - Best week of 2023 - NASDAQ up 6%! Microsoft - Big Move! - OpenAI and other AI has been good tailwind for the company - Stock closing in on ATH -- H&C Clients own the stock MSFT CHART FOLLOW UP : What to Expect from the Data Deluge - ISM on Friday (Services) - 53 vs 53 last - Employment - 160k and 3.8% (steady) - ISM Manufacturing 49 vs 49 (contraction) - FOMC Rate Decision (pause/pass/no change) - (Add in Treasury  issuance needed to make up deficit and  Apple earnings) ----- Result? Pretty much inline - Fed said one thing: Risk balanced about doing too much or too little and market went bananas --------Apple - Not impressive and outlook for this coming quarter not so good - but stock moves higher Countdown - November 17th is the end of the short-term budget extension Apple Earnings - EPS: $1.46 per share vs. $1.39 per share expected - Revenue: $89.5 billion vs. $89.28 billion expected - iPhone revenue: $43.81 billion vs. $43.81 billion expected - Mac revenue: $7.61 billion vs. $8.63 billion expected  - iPad revenue: $6.44 billion vs. $6.07 billion expected - Wearables revenue: $9.32 billion vs. $9.43 billion expected - Services revenue: $22.31 billion vs $21.35 billion expected - Gross margin: 45.2% vs. 44.5% expected - - Outlook - Not Great - and blamed one  less week in the 4th quarter on outlook -  - - Stock Down initially then rose with  market Skinny Drugs - Novo Nordisk said on Thursday it will supply "significantly" more doses of Wegovy in the U.S. next year, even as it cautioned shortages of the weight-loss injection would continue in the short to medium term. - The Danish drugmaker, which this year overtook LVMH as Europe's most valuable listed company, posted record operating profit and sales for the third quarter, underscoring the phenomenal success of Wegovy so far. -"Specifically on the U.S. market, we'll be supplying significantly more in 2024 compared to what we are in 2023," Novo's CFO Karsten Munk Knudsen said in an interview. - H&C clients own NVO for past several months More Drugs - - Moderna said its 2023 sales would only hit the low end of its $6 billion to $8 billion forecast, reflecting weaker demand for COVID-19 vaccines, and its shares slumped 8%. - The vaccine maker also pushed back to 2025 - Stock down 59% YTD Household Debt - "The Federal Reserve Bank of New York's Center for Microeconomic Data today issued its Quarterly Report on Household Debt and Credit. The Report shows total household debt increased by $228 billion (1.3%) in the third quarter of 2023, to $17.29 trillion. The report is based on data from the New York Fed's nationally representative Consumer Credit Panel. - Mortgage balances rose by $126 billion from the previous quarter and stood at $12.14 trillion at the end of September. - Credit card balances increased by $48 billion ...

What exactly is AI and how is it transformational? Where are markets going and why does the Fed want the economy to break? Our guest, Ross Gerber is naming names in the AI and Tech space that he likes right now.   Register for the November 15th, 2024 Webinar   Ross Gerber is the Co-Founder, President and CEO of Gerber Kawasaki Wealth and Investment Management. Ross oversees Gerber Kawasaki's corporate and investment management operations as well as serves individual clients. Ross has become one of the most followed investors on social and in traditional media. His investment ideas and advice have made him a regular in the business news and he is featured on CNN, CNBC, Fox Business News, Bloomberg and Reuters as well as a contributing writer for Forbes.com. He has been ranked as one of the most influential investment advisors and Fintech innovators in America*. Ross and the Gerber Kawasaki team oversees well over a billion dollars of investments focused on technology, media and entertainment companies for clients and the firm. Gerber Kawasaki has grown to be a leader in Fintech by leveraging technology to work with a younger generation of clients. Ross is an expert in online marketing and social media as well as co-developed the company's app for IOS. Check this out and find out more at: http://www.interactivebrokers.com/ Follow @andrewhorowitz Looking for style diversification? More information on the TDI Managed Growth Strategy - HERE Stocks mentioned in this episode: (TSLA), (AI), (MSFT), (AMZN), (XLK), (NVO), (NKE), (LULU)

By one count, a drugmaker founded in 1876 is a more expensive stock than Tesla. (Time Stamp)  Ricky Mulvey and Bill Barker discuss: - Tesla's CFO departure. - Eli Lilly hitting an all-time high, and the drugmaker's optimistic results. - How Burger King is driving sales growth with limited time offers. - Zoom calling its employees back to the office. Companies discussed: TSLA, LLA, NVO, QSR, ZM Host: Ricky Mulvey Guest: Bill Barker Engineer: Rick Engdahl

Weight loss drug sales are estimated to hit $44 billion by 2030. Many of these treatments can thank previously obscure research on a carnivorous deep sea fish for their development. Rolfe Winkler is a reporter for the Wall Street Journal covering digital health. Ricky Mulvey caught up with Winkler to discuss: - The origins and science behind weight loss drugs. - The challenge of selling lizard venom research to pharmaceutical companies. - What decades-old research on anglerfish reveals about modern side effects for Ozempic. - And why it's “not too hard” to keep dozens of Gila Monsters in your basement. “Monster Diet Drugs Like Ozempic Started With Actual Monsters”: https://www.wsj.com/articles/ozempic-mounjaro-gila-monster-anglerfish-8c9c1ff2 Companies mentioned: NVO, LLY Host: Ricky Mulvey Guest: Rolfe Winkler Engineers: Tim Sparks, Heather Horton

Telsa finally introduces the Cybertruck and Ford fights back with a price cut on the F-150Lightning. (00:21) Bill Barker and Deidre Woollard discuss: - The futuristic appeal of the Cybertruck compared to more traditional models. - Why Ford announced a price drop on the F-150 Lightning. - How Eli Lilly could win big in the weight-loss wars. (18:53) The majority of borrowers haven't been paying off their student loan debt. Matt Frankel explains what the resumption of payments could mean for the economy. Companies discussed:  F, TSLA, GM, LLY,  NVO, SOFI, NNI Host: Deidre Woollard Guests: Bill Barker, Ricky Mulvey Producer: Ricky Mulvey Engineers: Dan Boyd, Tim Sparks